AI assistant
Sending…
NEKTAR THERAPEUTICS — Director's Dealing 2023
Apr 26, 2023
32134_dirs_2023-04-25_d9defba9-42dc-4df1-9b89-0d3de971208a.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: NEKTAR THERAPEUTICS (NKTR)
CIK: 0000906709
Period of Report: 2023-04-17
Reporting Person: GARDINER SANDRA A. (Chief Financial Officer)
More from NEKTAR THERAPEUTICS
Declaration of Voting Results & Voting Rights Announcements
2026
Jun 5
Capital/Financing Update
2026
May 8
Annual Report
2026
Apr 24
Capital/Financing Update
2026
Apr 23
Capital/Financing Update
2026
Apr 23
Capital/Financing Update
2026
Apr 20
Regulatory Filings
2026
Apr 20
Regulatory Filings
2026
Apr 20
Major Shareholding Notification
2026
Mar 27
Director's Dealing
2026
Feb 20